Merus B.V., a biopharmaceutical company focusing on innovative human antibody therapeutics, today announced that it has significantly expanded its capabilities to generate large collections of distinct, unique bispecific antibodies against target combinations by contracting R&D services to FairJourney Biologics. Under an agreement signed with Merus, FairJourney Biologics will provide R&D services to strengthen Merus R&D … Continue reading FairJourney Biologics signed an agreement to provide R&D services for Merus B.V. to expand its antibody discovery capacity